Avantor (Avantor) Debt-to-Equity : 1.00 (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Avantor Debt-to-Equity?

Avantor's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $299 Mil. Avantor's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $5,024 Mil. Avantor's Total Stockholders Equity for the quarter that ended in Mar. 2024 was $5,336 Mil. Avantor's debt to equity for the quarter that ended in Mar. 2024 was 1.00.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Avantor's Debt-to-Equity or its related term are showing as below:

AVTR' s Debt-to-Equity Range Over the Past 10 Years
Min: -2.72 Med: 1.46 Max: 2.21
Current: 1

During the past 8 years, the highest Debt-to-Equity Ratio of Avantor was 2.21. The lowest was -2.72. And the median was 1.46.

AVTR's Debt-to-Equity is ranked worse than
85.11% of 1397 companies
in the Chemicals industry
Industry Median: 0.35 vs AVTR: 1.00

Avantor Debt-to-Equity Historical Data

The historical data trend for Avantor's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avantor Debt-to-Equity Chart

Avantor Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

2.08

1.83

1.67

1.30

1.05

Avantor Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-Equity	Get a 7-Day Free Trial															1.21	1.17	1.10	1.05	1.00

Competitive Comparison of Avantor's Debt-to-Equity

For the Specialty Chemicals subindustry, Avantor's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Avantor's Debt-to-Equity Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Avantor's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Avantor's Debt-to-Equity falls into.

Avantor Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Avantor's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(259.9	+	5276.7)	/	5252.6
	=	1.05

Avantor's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(299.1	+	5023.9)	/	5336.3
	=	1.00

Avantor (NYSE:AVTR) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Avantor Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Avantor's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Avantor (Avantor) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Avantor Inc (NYSE:AVTR) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

AVG:Germany

Address

100 Matsonford Road, Suite 200, Building One, Radnor Corporate Center, Radnor, PA, USA, 19087

Website

https://www.avantorsciences.com

Avantor Inc is involved in providing products and services to biopharma, healthcare, education and government, and advanced technologies and applied materials industries. The company's offerings include materials and consumables, equipment and instrumentation and services and specialty procurement. Its brand profile consists of NuSil, RANKEM, POCH, BeneSphera, and Macron Fine Chemicals among others. The firm operates in three geographical segments namely Americas, Europe, and AMEA. It generates a majority of its revenue from the Americas.

Executives

Benoit Gourdier	officer: EVP, Biopharma Production	100 MATSONFORD ROAD, RADNOR PA 19087
Steven W Eck	officer: SVP & Chief Accounting Officer	C/O CSS INDUSTRIES, INC., 450 PLYMOUTH ROAD, SUITE 300, PLYMOUTH MEETING PA 19462
Frederic Vanderhaegen	officer: EVP, Europe	C/O AVANTOR, INC., 100 MATSONFORD ROAD, RADNOR PA 19087
Brittany Hankamer	officer: EVP, Chief HR Officer	100 MATSONFORD ROAD, RADNOR PA 19087
R. Brent Jones	officer: EVP, Chief Financial Officer	C/O PALL CORPORATION, 25 HARBOR PARK DRIVE, PORT WASHINGTON NY 11050
Claudius Sokenu	officer: EVP, Chief Legal & Compliance	C/O UNISYS CORPORATION, 801 LAKEVIEW DRIVE, BLUE BELL PA 19422
Randy Lee Stone	officer: EVP, Proprietary Products	974 CENTRE ROAD, CRP 730, WILMINGTON DE 19805
Christophe Couturier	officer: See Remarks	9 FOURTH AVENUE, C/O OVASCIENCE INC., CAMBRIDGE MA 02451
Gerard Brophy	officer: EVP, Biopharma Production	C/O AVANTOR, INC., 100 MATSONFORD ROAD, RADNOR PA 19087
Kitty Sahin	officer: EVP, Strategy&Corp Development	100 MATSONFORD ROAD, RADNOR PA 19087
Thomas A Szlosek	officer: EVP and CFO	HONEYWELL INTERNATIONAL INC., 115 TABOR ROAD, MORRIS PLAINS NJ 07950
Michael Stubblefield	director, officer: President and CEO	C/O AVANTOR, INC., 100 MATSONFORD ROAD, RADNOR PA 19087
Rajiv Gupta	director	234 RAVENCLIFF DRIVE, ST DAVIDS PA 19087
Joseph R Massaro	director	5725 DELPHI DRIVE, TROY MI 48098
Mala Murthy	director	C/O TELADOC HEALTH, INC., 2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577